The 5-on/2-off schedule, the bedtime timing, the 3-month cycle with a rest period, the reconstitution method: none of these are suggestions
Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications
The amount depends on which peptide you are using, your experience level, and your goals
Of note, the therapeutic effect of BPC 157 was promising since it took place at 10 min post-compression injury, in the already advanced reperfusion phase (note, in the spinal cord injured rats, there was a permanent reperfusion), and it was uninterrupted as no spontaneous spinal cord injury-induced disturbances reappeared [1]
Further studies showed that it helps provide weight loss better than diet alone